Tc-99m MDP and Tc-99m MIBI in the assessment of spondyloarthritis presenting as bone metastasis before treatment with infliximab

Clin Nucl Med. 2002 Apr;27(4):297-8. doi: 10.1097/00003072-200204000-00015.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis / diagnostic imaging*
  • Arthritis / drug therapy
  • Bone Neoplasms / diagnostic imaging*
  • Bone Neoplasms / secondary*
  • Bone and Bones / diagnostic imaging*
  • Humans
  • Infliximab
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Radionuclide Imaging
  • Radiopharmaceuticals*
  • Spinal Diseases / diagnostic imaging*
  • Spinal Diseases / drug therapy
  • Technetium Tc 99m Medronate*
  • Technetium Tc 99m Sestamibi*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Radiopharmaceuticals
  • Technetium Tc 99m Sestamibi
  • Infliximab
  • Technetium Tc 99m Medronate